What is the equity of Bionime this year?
Bionime has equity of 1.99 B TWD this year.
Bionime Equity 2024
Bionime Equity
1.99 B TWD
Ticker
4737.TW
ISIN
TW0004737002
In 2024, Bionime's equity was 1.99 B TWD, a -4.17% increase from the 2.07 B TWD equity in the previous year.
Bionime Aktienanalyse
What does Bionime do?
Bionime Corp is a company that was founded in 2003 and specializes in the development and manufacture of medical devices for measuring blood sugar levels and other cardiovascular tests. Bionime ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Bionime's Equity
Bionime's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Bionime's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Bionime's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Bionime's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Bionime’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Bionime stock
What was the equity of Bionime compared to the previous year?
The equity of Bionime has increased/decreased by -4.17% decreased compared to the previous year.
What impact does a high equity have on investors of Bionime?
A high equity is advantageous for investors of Bionime as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Bionime?
A low equity can be a risk for investors of Bionime, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Bionime affect the company?
An increase in equity of Bionime can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Bionime affect the company?
A reduction in equity of Bionime can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Bionime?
Some factors that can affect the equity of Bionime include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Bionime so important for investors?
The equity of Bionime is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Bionime take to change the equity?
To change equity, Bionime can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Bionime pay?
Over the past 12 months, Bionime paid a dividend of 2.1 TWD . This corresponds to a dividend yield of about 3.13 %. For the coming 12 months, Bionime is expected to pay a dividend of 2.1 TWD.
What is the dividend yield of Bionime?
The current dividend yield of Bionime is 3.13 %.
When does Bionime pay dividends?
Bionime pays a quarterly dividend. This is distributed in the months of August, August, August, August.
How secure is the dividend of Bionime?
Bionime paid dividends every year for the past 15 years.
What is the dividend of Bionime?
For the upcoming 12 months, dividends amounting to 2.1 TWD are expected. This corresponds to a dividend yield of 3.13 %.
In which sector is Bionime located?
Bionime is assigned to the 'Health' sector.
Wann musste ich die Aktien von Bionime kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Bionime from 8/23/2024 amounting to 1.999 TWD, you needed to have the stock in your portfolio before the ex-date on 7/29/2024.
When did Bionime pay the last dividend?
The last dividend was paid out on 8/23/2024.
What was the dividend of Bionime in the year 2023?
In the year 2023, Bionime distributed 1.999 TWD as dividends.
In which currency does Bionime pay out the dividend?
The dividends of Bionime are distributed in TWD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Bionime
Our stock analysis for Bionime Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bionime Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.